Linaclotide found to benefit patients aged 6-17 with functional constipation Dr. Kamal Kant Kohli26 Sept 2022 7:30 PM ISTPositive Topline Data of benefits of linaclotide in Functional Constipation in pediatric Patients Aged 6-17 with Functional Constipation have been...
Gadopiclenol gets FDA approval as new contrast agent for MRI Dr. Kamal Kant Kohli25 Sept 2022 7:30 PM ISTUSA: A new magnetic resonance imaging (MRI) contrast agent, Gadopiclenol, has received US Food and Drug Administration's (FDA's) approval....
FDA approves sodium thiosulfate for for cisplatin-related ototoxicity in children Dr. Kamal Kant Kohli22 Sept 2022 8:30 PM ISTAs of now there have been no approved treatments for preventing cisplatin-induced hearing loss. The US Food And Drug Administration has approved...
NSAIDs intake prior to removal of ureteral stent fails to reduce pain in pediatric patients Dr. Kamal Kant Kohli18 Sept 2022 8:30 PM ISTPediatric patients did not experience a significant difference in pain levels following ureteral stent removal between those who took a non-steroidal...
Partial splenectomy preserves splenic function for benign lesions in pediatric patients Dr. Shravani Dali15 Aug 2022 7:00 PM ISTPartial and total splenectomy results in a good prognosis in benign splenic lesions in pediatric patientsaccording to a recent study published in the...
FDA approves belimumab for lupus nephritis for pediatric patients Dr. Kamal Kant Kohli28 July 2022 10:15 AM ISTThe FDA has approved belimumab for the treatment of active lupus nephritis for children who are also receiving standard therapy. The drug is being...
Vaccination of children with autoimmune inflammatory rheumatic diseases: EULAR/PRES recommendations Medha Baranwal27 July 2022 7:15 PM ISTNetherlands: An article, published in Annals of the Rheumatic Diseases, reports updated EULAR/PRES recommendations for vaccination of pediatric...
FDA approves treatment for chronic weight in pediatric patients aged 12 years and older Dr. Kamal Kant Kohli30 Jun 2022 6:00 AM ISTThe U.S. Food and Drug Administration (FDA) has extended approval of Qsymia (phentermine and topiramate extended-release capsules) for chronic weight...
New Super-Pulsed Thulium Fiber Laser Improves outcomes in Pediatric Patients with Urinary Stones Dr. Kamal Kant Kohli28 Jun 2022 8:00 PM IST A new thulium fiber laser system may provide improved outcomes in the treatment of urinary stones for pediatric patients, compared to the...
FDA approves dupilumab for treatment of atopic dermatitis in pediatric patients Dr. Kamal Kant Kohli10 Jun 2022 9:00 AM ISTTARRYTOWN, N.Y. and PARIS: The U.S. Food and Drug Administration (FDA) has approved Dupixent® (dupilumab) for children aged 6 months to 5 years with...
FDA approves dupilumab as first Treatment for Eosinophilic Esophagitis Dr. Kamal Kant Kohli23 May 2022 9:15 AM ISTDupilumab (Dupixent, Regeneron Pharmaceuticals, Inc.) is first drug in the U.S. specifically indicated for the treatment of eosinophilic...
Dasiglucagon cuts IV glucose requirement in Pediatric Patients with Congenital Hyperinsulinism: Phase 3 Trial Dr. Kamal Kant Kohli20 May 2022 7:45 PM ISTreducing the requirement for IV glucose
